The ASCO Post: Challenges, Progress, and Future Directions in Head and Neck Cancer

 – March 6, 2012 /Press Release/  –– 

Although head and neck cancer remains a major therapeutic challenge, significant advances have been made over the past few decades. The ASCO Post recently spoke with Marshall R. Posner, MD, Medical Director of the Head and Neck Oncology Program, The Mount Sinai Medical Center, New York, about the current state of therapies and exciting new opportunities in this difficult-to-treat disease. “Primary treatment modalities – surgery and radiation – have produced significant improvements in morbidity,” said Dr. Posner. “Transoral robotic surgery has reduced trauma and tissue damage associated with deep resections within the oropharynx and larynx, thus improving functional outcomes and changing the way we approach early-stage cancers.”  Learn More